TY - JOUR
T1 - Critical roles of G protein-coupled receptors in regulating intestinal homeostasis and inflammatory bowel disease
AU - Feng, Zhongsheng
AU - Sun, Ruicong
AU - Cong, Yingzi
AU - Liu, Zhanju
N1 - Publisher Copyright:
© 2022, The Author(s), under exclusive licence to Society for Mucosal Immunology.
PY - 2022/5
Y1 - 2022/5
N2 - G protein-coupled receptors (GPCRs) are a group of membrane proteins that mediate most of the physiological responses to various signaling molecules such as hormones, neurotransmitters, and environmental stimulants. Inflammatory bowel disease (IBD) is a chronic relapsing disorder of the gastrointestinal tract and presents a spectrum of heterogeneous disorders falling under two main clinical subtypes including Crohn’s disease (CD) and ulcerative colitis (UC). The pathogenesis of IBD is multifactorial and is related to a genetically dysregulated mucosal immune response to environmental drivers, mainly microbiotas. Although many drugs, such as 5-aminosalicylic acid, glucocorticoids, immunosuppressants, and biological agents, have been approved for IBD treatment, none can cure IBD permanently. Emerging evidence indicates significant associations between GPCRs and the pathogenesis of IBD. Here, we provide an overview of the essential physiological functions and signaling pathways of GPCRs and their roles in mucosal immunity and IBD regulation.
AB - G protein-coupled receptors (GPCRs) are a group of membrane proteins that mediate most of the physiological responses to various signaling molecules such as hormones, neurotransmitters, and environmental stimulants. Inflammatory bowel disease (IBD) is a chronic relapsing disorder of the gastrointestinal tract and presents a spectrum of heterogeneous disorders falling under two main clinical subtypes including Crohn’s disease (CD) and ulcerative colitis (UC). The pathogenesis of IBD is multifactorial and is related to a genetically dysregulated mucosal immune response to environmental drivers, mainly microbiotas. Although many drugs, such as 5-aminosalicylic acid, glucocorticoids, immunosuppressants, and biological agents, have been approved for IBD treatment, none can cure IBD permanently. Emerging evidence indicates significant associations between GPCRs and the pathogenesis of IBD. Here, we provide an overview of the essential physiological functions and signaling pathways of GPCRs and their roles in mucosal immunity and IBD regulation.
UR - http://www.scopus.com/inward/record.url?scp=85132544446&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85132544446&partnerID=8YFLogxK
U2 - 10.1038/s41385-022-00538-3
DO - 10.1038/s41385-022-00538-3
M3 - Review article
C2 - 35732818
AN - SCOPUS:85132544446
SN - 1933-0219
VL - 15
SP - 819
EP - 828
JO - Mucosal Immunology
JF - Mucosal Immunology
IS - 5
ER -